Top Tech Companies (764)
Don't see your company?
Create a company profile
CoJourney CO. is reimagining cell and gene therapy CDMO services globally. Our platform is built on High Purity, High Yield, On Time Supply and Significantly Reduced Costs. We provide process development and clinical and commercial mfg. through a range of platform technologies, including: (1) Plasmids, (2) mRNA, (3) AAV / adenovirus, (4) Lentivirus, (5) Retrovirus, (6) Custom Viral Vectors. We have proprietary high-purity, high-yield, streamlined and cost-effective processes and our facilities are compliant under US FDA, EU EMA and China NMPA Plasmid, mRNA, and Viral Vector development, manufacturing and import/export regulations. Plasmids are manufactured in a multi-product cGMP facility that includes multiple upstream suites, downstream suites and a fill-finish suite with an isolator and filler. The facility includes 30L disposable fermenters for plasmid production. Viral Vectors are manufactured in a cGMP viral vector facility that includes multiple upstream cell culture, upstream viral vector production suites, downstream processing and fill-finish suites. The facility includes 500L and 2,000L disposable bioreactors for viral vector production. CoJourney’s Process Development labs allow separate, client specific project rooms and are equipped with state of the art and large-scale equipment. The analytical development and Quality Control laboratories provide state of the art analytical equipment are focused on analytical development and performing all stages of release testing for plasmids and viral vectors. CoJourney is currently manufacturing AAV-based gene therapies that have been approved for use in global clinical trials: 1) rAAV based gene therapy for Neurovascular Age-Related Macular Degeneration (wet AMD) in USA 2) AAV based gene therapy for Spinal Muscular Atrophy (SMA) in China Please contact us to discuss how our innovative approaches and timely, cost-effective solutions can address your needs. Please contact us for more information.
Peptide Logic is a biopharmaceutical company developing peptide-antibody conjugates for pain.
Medisyn Technologies is a unique bioactive compound design and discovery company for novel pharmaceuticals, nutraceuticals and animal health products. Through its proprietary Forward Engineering™ technology platform, Medisyn makes bioactive compound discovery faster, more predictable and less expensive. Based on molecular topology, Medisyn’s platform enables the discovery and design of novel, diverse and unexpected compounds in new chemical classes that meet exact parameters for a specific therapeutic use. By compressing design and discovery time from years to months and optimizing lead candidates, Medisyn’s novel approach enables customers to reduce risk, improve probability of success and control costs associated with the traditional lead discovery process.
Adaptimmune, a leader in T-cell therapy, is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary SPEAR T-cell receptor platform to treat solid tumors, which has the potential to transform the treatment of cancer. Our proprietary SPEAR T-cell platform has generated a strong pipeline of affinity-enhanced T-cell therapies, with multiple INDs open. We use these therapies to harness the body's own immune system to find and destroy diseased cells. Our SPEAR TCR therapies offer promise to patients that often have no other options. We are working hard to make that promise a reality.
Alphanumeric is leading life science and healthcare organizations toward a more efficient future - where patients and providers are met with personalized communication at every stage of their journey. Our teams are driven to improve and enhance interpersonal and patient experiences across industries. We provide more than call centers - we go beyond them to provide top-tier customer service, patient experience support, and HCP engagement that exceed expectations.
CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.
CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. In achieving this goal, we look to radically transform the pharmaceutical manufacturing industry, steering it away from outdated batch systems to state-of-the-art continuous processes. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. With ICM, we will improve affordability and accessibility of pharmaceuticals on a global scale. Our work is critical because the current manufacturing systems are time- and cost-inefficient, and are beset with quality problems. It is not unusual for manufacturing lead times, from start to finish, to be over one year, and studies have shown that the industry loses over $50 B annually due to wasteful processes. More importantly, these problems impact patient care. Hundreds of drugs are placed on the US FDA drug shortage website, many of which are life-saving (e.g., oncology drugs). To solve these problems, we offer a number of solutions: In addition, CONTINUUS is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States. To achieve our goals, CONTINUUS has assembled a team of talented engineers and scientists, with skills ranging from analytical chemistry to drug formulation. Rather than producing medicines through batch-wise, step-by-step processes, ICM allows for fully continuous and automated operations, where the synthesis of the active ingredient and the final dosage form are integrated into a seamless process. This novel method will allow “on-demand” manufacturing of pharmaceuticals, improving affordability and accessibility of pharmaceuticals on a global scale.
Segal Trials, founded in 1998, is a privately held network of seven research sites throughout South Florida conducting Phase I-IV research trials with a primary emphasis on psychiatry, neurology, addiction, insomnia, general medicine, healthy volunteers, infectious diseases, vaccines, and women’s health. Staying true to its core values of quality, customer service, advocacy, and patient care, the Segal Trials team of over 110 professionals remains agile and competitive, expanding and growing based on the needs of its sponsors and its patients. Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical in the advancement of medicine and making available new and helpful medications. It is Segal Trials’ mission to play an integral role in the advancement process and help millions of people suffering from diseases.
Enclara Pharmacia is a supplier of medications and clinical services
Pharmaceutical distributors
.jpeg)
.png)
At BioNex Solutions, we develop instrumentation and integrated systems that solve the most demanding applications in biopharmaceutical, biotech, and academic research. Our hardware and software philosophy is to design single-purpose, high performance modules, and integrate them to produce the desired functionality. Rather than push a single, generalized product that tries to meet the needs of every customer, we prefer to tailor our control software to each customers' needs to make operation as simple as possible. ISO 9001:2008 & ISO 13485:2003 Certified
EquipNet, Inc. is the world leader in proactive asset management services and solutions for large and small corporations alike. We specialize in the pharmaceutical, biotech, chemical, semiconductor, aerospace, automotive, and consumer packaged goods industries, as well as many other markets. EquipNet’s vision is to revolutionize the way companies manage their surplus assets. Forward-thinking corporations such as Merck, Johnson & Johnson, Unilever, Novartis and many others use EquipNet's Cascading Model™ to maximize financial returns, meet critical deadlines, avoid unnecessary costs, and prevent health, environmental, and theft hazards associated with idle assets.
PCI is a pharmaceutical company specializing in calibration and data analysis services.
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.” For more information, please visit www.daiichisankyo.com.
Circumvent Pharmaceuticals is a Pharmaceuticals company.
Endo Pharmaceuticals Inc., headquartered in Malvern, PA, develops and markets high-value, quality branded pharmaceutical products for patients in need. Endo Pharmaceuticals’ specialty portfolio includes products for urology, men’s health, orthopedics and endocrinology. Endo Pharmaceuticals is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.
Clinical Solutions Group is a pharmaceutical company offering drug development services.
We’re designing a better way to deliver and pay for health while engaging and guiding a community of members to live their best health. As a national, team-based medical group with a focus on wellbeing and prevention that extends beyond traditional sick care, we deliver Primary Health. An entirely new model of health, Primary Health is driven by an interdisciplinary team that builds relationships with members to proactively move them towards their best health using measurement-based care. Join our movement as we create the future of health as it should be
Tech Pharmacy Services, Inc., doing business as Advanced Pharmacy, designs, develops, implements, and services technology-based solutions.
MiMedx is a biopharmaceutical company.
